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imaging in dementia with Lewy bodies,
Alzheimer’s disease, vascular dementia, and
normal aging
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Abstract
Objectives—Alzheimer’s disease and vas-
cular dementia are associated with an
increase in changes in white matter on
MRI. The aims were to investigate
whether white matter changes also occur
in dementia with Lewy bodies and to
examine the relation between white mat-
ter lesions and the cognitive and non-
cognitive features of dementia with Lewy
bodies, Alzheimer’s disease, and vascular
dementia.
Methods—Proton density and T2 weighted
images were obtained on a 1.0 Tesla MRI
scanner in patients with dementia with
Lewy bodies (consensus criteria; n=27,
mean age=75.9 years), Alzheimer’s disease
(NINCDS/ADRDA; n=28, mean age=77.4
years), vascular dementia (NINDS/AIREN;
n=25, mean age=76.8 years), and normal
controls (n=26, mean age=76.2 years).
Cognitive function, depressive symptoms,
and psychotic features were assessed using
a standardised protocol. Periventricular
hyperintensities (PVHs), white matter hy-
perintensities (WMHs) and basal ganglia
hyperintensities (BGHs) were visually
rated blind to diagnosis using a semiquan-
titative scale.
Results—Periventricular hyperintensities
were positively correlated with age and
were more severe in all dementia groups
than controls. Total deep hyperintensities
scores (WMHs plus BGHs) were signifi-
cantly higher in all dementia groups than
controls and higher in patients with vascu-
lar dementia than those with dementia with
Lewy bodies or Alzheimer’s disease. In all
patients with dementia, frontal WMHs
were associated with higher depression
scores and occipital WMHs were associated
with an absence of visual hallucinations
and delusions.
Conclusion—In common with Alzheimer’s
disease and vascular dementia, PVHs and
WMHs were significantly more extensive in
dementia with Lewy bodies than in con-
trols. This overlap between diVerent de-
mentias may reflect shared pathological
mechanisms. The link between frontal
WMHs and depression and the absence of
occipital WMHs and psychotic symptoms
has important implications for under-
standing the neurobiological basis of these
symptoms.
(J Neurol Neurosurg Psychiatry 1999;67:66–72)
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Magnetic resonance imaging can detect hyper-
intense white matter lesions, especially with pro-
ton density and T2 weighted scans. These
changes can be divided into those immediately
adjacent to the ventricles (periventricular hyper-
intensities; PVHs) and those located in the deep
white matter (white matter hyperintensities;
WMHs). Periventricular hyperintensities and
WMHs probably result from diVerent patho-
logical processes and have been described in
various conditions including normal aging,1 vas-
cular dementia,2 and Alzheimer’s disease.3
The prevalence, severity, and distribution of
PVHs and WMHs seem to vary between
diVerent disorders and with age. Vascular
dementia is associated with increased PVHs
and WMHs compared with Alzheimer’s dis-
ease and age matched normal controls.4 5
Patients with Alzheimer’s disease also have
more extensive PVHs than controls6–10 but
there are conflicting findings in relation to
WMHs. Bowen et al7 found that WMHs were
increased in patients with Alzheimer’s disease
compared with controls, Scheltens et al11 found
an increase only in late onset patients although
others have found no diVerence.10 12–14 Incon-
sistency between studies may be attributable to
variation in scanning techniques, sample size
and selection, and the rating scales used.15 16
Dementia with Lewy bodies has been
recently recognised as a major cause of
dementia,17 clinically and neuropathologically
distinct from Alzheimer’s disease and vascular
dementia.18 It is probably the second common-
est form of late life dementia, accounting for up
to 20% of cases. Dementia with Lewy bodies is
characterised by the triad of visual hallucinosis,
fluctuating cognitive impairment, and parkin-
sonism. Pathologically, intracytoplasmic,
neuronal inclusion bodies (Lewy bodies) are
found in the neocortex, limbic cortex, subcor-
tical nuclei, and brainstem. There have been
few neuroimaging studies of dementia with
Lewy bodies and changes in white matter on
MRI in this disease have not previously been
investigated.
The clinical importance of changes in white
matter seen on MRI in dementia is poorly
understood. There is growing evidence that
changes in white matter are linked to depres-
sive illness in late life3 9 and possibly psychotic
symptoms in late onset schizophrenia.19 20
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Whether white matter lesions are involved in
the pathogenesis of depressive and psychotic
symptoms in dementias is unclear.
The aims of this study were to compare
white matter changes on MRI in patients with
dementia with Lewy bodies with those with
Alzheimer’s disease, vascular dementia, and
normal age matched controls, and to examine
their relation to cognitive and non-cognitive
features of dementia. Our hypothesis was that,
in common with Alzheimer’s disease and
vascular dementia, an increased prevalence of
changes in white matter would occur in
dementia with Lewy bodies. We also tested the
hypothesis that changes in white matter in late
onset dementias are associated with depressive
and possibly psychotic symptoms. A represen-
tative sample of community dwelling elderly
subjects was included and white matter lesions
were rated using a semiquantitative scale21 to
record the prevalence, severity, and anatomical
distribution of these changes.
Methods
SELECTION OF PATIENTS WITH DEMENTIA
Eighty patients over the age of 60 years who
fulfilled DSM IV22 criteria for dementia were
recruited. Seventy five patients were obtained
from a community dwelling population of
patients referred to local old age psychiatry and
geriatric medicine services for evaluation of
possible dementia. Five patients were recruited
from a dementia research clinic. The research
was approved by the local ethics committee
and all patients, as well as their nearest relative,
gave informed consent.
ASSESSMENTS AND DIAGNOSIS
Diagnosis was made after a detailed clinical
assessment. This included an interview with
the subject and the most knowledgeable
informant using the geriatric mental state/
history aetiology schedule,23 review of clinical
records, full psychiatric and medical history,
and mental state and physical examination. A
standard dementia screen was completed
which included haematology and biochemistry
analysis, thyroid function tests, syphilis serol-
ogy, B12 and folate concentrations, and CT.
Standardised clinical diagnostic criteria were
used to characterise the type of dementia.
Diagnoses of Alzheimer’s disease, vascular
dementia, and dementia with Lewy bodies
were made in accordance with
NINCDS/ADRDA,24 NINDS/AIREN25 and
dementia with Lewy bodies consensus criteria17
respectively by consensus agreement between
three experienced raters (JO’B, CB, IMcK).
Diagnosis was made blind to MRI findings.
Pathological confirmation of clinical diagnosis
has since been acquired in four patients.
Applying these criteria, 28 patients had
Alzheimer’s disease (definite n=2, probable
n=24, and possible n=2), 25 had vascular
dementia (probable n=15 and possible n=10),
and 27 had dementia with Lewy bodies
(definite n=2, probable n=24, and possible
n=1).
Within three months of completing MRI all
patients underwent a further assessment. Cog-
nitive function was measured using the Cam-
bridge cognitive examination26 which incorpo-
rates the mini mental state examination
(MMSE).27 Depressive symptoms were rated
using the Montgomery and Asberg depression
rating scale (MADRS)28 and a history of
psychotic symptoms (delusions, misidentifica-
tions, auditory hallucinations, and visual hallu-
cinations) since onset of dementia was re-
corded using the Columbia University scale for
psychopathology in Alzheimer’s Disease,
(CUSPAD).29
NORMAL CONTROLS
Twenty six age matched controls were re-
cruited from among spouses and friends of
patients with dementia. A detailed history and
examination were undertaken to include de-
mographic data and physical and psychiatric
status. All control subjects completed the same
assessments as listed above: CAMCOG,
MMSE, MADRS, CUSPAD. Exclusion crite-
ria were evidence of current depression (from
history or MADRS>10) or dementia (from
history or score<80 on the CAMCOG) and
history of any other significant neurological,
physical, or psychiatric disorder including drug
and alcohol misuse.
MRI SCANNING PROTOCOL
All scans were performed on a 1.0 Tesla
Siemens Magnetom Impact MRI scanner.
Whole brain axial images of 5 mm thickness
(0.5 mm gap) were obtained using proton den-
sity weighted and T2 weighted turbo/fast spin
echo sequences to allow detailed visualisation
of white matter lesions (RARE technique-rapid
acquisition with relaxation enhancement:
TR=2800 ms; TE 14/85 ms; matrix 256×256;
field of view=23 mm giving pixel
size=0.92×0.92 mm; acquisition time=4 min
13s).
WHITE MATTER RATING
Using a standardised scale21 white matter
lesions were rated from hard copies of proton
density and T2 weighted axial images by an
experienced rater (PS) blind to diagnosis. The
scale provided a semiquantitative measurement
of the type, size, frequency, and location of
PVHs and WMHs, as shown in table 1. Hyper-
intensities were rated in five regions: frontal,
Table 1 Visual rating of signal hyperintensities
Lesions Score
Periventricular hyperintensities (PVH 0–6) Frontal caps (0–2) 0=absent
Occipital caps (0–2) 1=<5 mm
Bands: (0–2) 2=>5 mm and <10 mm
White matter hyperintensities (WMH 0–24) Frontal (0–6) 0=NA
Parietal (0–6) 1=<3 mm; n<5
Occipital (0–6) 2=<3 mm; n>6
Temporal (0–6) 3=4–10 mm; n<5
4=4–10 mm; n>6
5=>11 mm; n>1
6=confluent
Basal ganglia hyperintensities (BGH 0–30) Caudate nucleus (0–6) As for WMH
Putamen (0–6)
Globus pallidus (0–6)
Thalamus (0–6)
Internal capsule (0–6)
Semiquantitative rating of signal hyperintensities in separate regions with the range of the scale
shown in parentheses: n=number of lesions; NA=no abnormality.
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temporal, parietal, occipital, and basal ganglia
(BGH).
STATISTICAL ANALYSIS
The statistical package SPSS for Windows
(Release 7.0) was used for data analysis.30 Dif-
ferences between groups on continuous vari-
ables were assessed using analysis of variance
(ANOVA) with post hoc ScheVé tests to deter-
mine group diVerences. For non-parametric
data a Kruskal-Wallis test was used followed by
a post hoc Mann-Whitney U test or Pearson ÷2
statistic as appropriate, with Fisher’s exact
probability test calculated for 2×2 tables when
the expected cell frequency was <5. Associa-
tions between white matter lesions and clinical
variables were examined using the Mann-
Whitney U test or Spearman’s rank order cor-
relation coeYcient (r) as appropriate. All
statistical tests were two tailed and were
regarded as significant at p<0.01 for correla-
tions and p<0.05 for all other tests.
Results
SUBJECT CHARACTERISTICS
Subject characteristics are summarised in
table 2. Groups were well matched for age, sex,
history, and years of education. As would be
expected, CAMCOG and MMSE scores were
significantly lower in all dementia groups com-
pared with controls (p<0.001). Patients with
dementia with Lewy bodies were significantly
more impaired than those with vascular
dementia on MMSE (13.6 v 18.2; p<0.05) and
CAMCOG (46.1 v 62.0; p<0.05).
There were no diVerences between dementia
groups for MADRS scores although all demen-
tia groups had significantly more depressive
symptoms than controls (p<0.05). Patients
with dementia with Lewy bodies experienced
significantly more delusions (p<0.001), visual
hallucinations (p<0.001), and auditory halluci-
nations (p=0.01) than those with Alzheimer’s
disease and vascular dementia.
PERIVENTRICULAR HYPERINTENSITIES
The results for PVHs are summarised in
table 3. All dementia groups had significantly
higher total PVH scores (sum of bands and
caps) compared with controls (p=0.001).
There were no significant diVerences between
dementia with Lewy bodies, Alzheimer’s dis-
ease, and vascular dementia, and overall PVHs
were present in all dementia patients (100%)
and nearly all age matched controls (92%).
Analysing bands and caps separately, periv-
entricular bands were significantly more severe
in patients with Alzheimer’s disease (p<0.01)
and vascular dementia (p<0.05) than in
controls, and occipital caps were more severe
(p<0.001) and frequent in all dementia groups
compared with controls (dementia with Lewy
bodies 82%, vascular dementia 80%,
Alzheimer’s disease 75% v controls 31%;
p=0.001). By contrast, frontal caps were com-
mon to all groups (vascular dementia 96%,
Alzheimer’s disease 93%, dementia with Lewy
bodies 92%, controls 89%).
Periventricular hyperintensities were posi-
tively correlated with age in all patients (total
PVH score r=0.41, p<0.001) but were not
associated with cognitive impairment or de-
pressive and psychotic symptoms.
WHITE MATTER AND BASAL GANGLIA
HYPERINTENSITIES
The results for WMHs and basal ganglia
lesions are presented in table 4. Photographs of
MRI demonstrating white matter changes in
subjects from each group are shown in the
figure.
Table 2 Subject characteristics
DLB
(n=27)
AD
(n=28)
VaD
(n=25)
Con
(n=26) p Value
Age (mean (SD)) 75.9 (7) 77.4 (5) 76.8 (7) 76.2 (5) NS
Sex (M:F) 19:9 10:18 15:10 14:12 NS
Education (years (SD)) 9.1 (1) 9.7 (3) 9.9 (1) 10.1 (2) NS
Length of history (months (SD)) 38.2 (19) 42.4 (25) 39.7 (25) NS NS
MMSE (mean (SD)) 13.6 (7) 15.5 (5) 18.2 (4) 28.1 (2) <0.001*
CAMCOG (mean (SD)) 46.1 (26) 55.5 (16) 62.0 (13) 97.2 (5) <0.001*
MADRS (mean) 8.0 7.6 7.7 3.4 <0.05
Delusions (%) 18 (67) 11 (39) 5 (20) 0 <0.001
Visual hallucinations (%) 23 (85) 3 (11) 3 (12) 0 <0.001
Auditory hallucinations (%) 14 (52) 4 (14) 0 (0) 0 =0.01
Con=Controls; DLB=dementia with Lewy bodies; AD=Alzheimer’s disease; VaD=vascular
dementia.
*post hoc ScheVé test showed significant diVerences between Con and AD, Con and VaD, Con
and DLB (p<0.001), and between VaD and DLB (p<0.05).
Table 3 Periventricular hyperintensities
DLB
(n=27)
AD
(n=28)
VaD
(n=25) Con (n=26) p Value
Bands:
Prevalence 23 (85%) 28 (100%) 24 (96%) 19 (73%)
Median score 1 1 1 1 <0.05*
Frontal caps:
Prevalence 25 (93%) 26 (93%) 24 (96%) 23 (89%)
Median score 1 1 1 1 NS
Occipital caps:
Prevalence 22 (82%) 21 (75%) 20 (80%) 8 (31%)
Median score 1 1 1 0 <0.001†
Total PVH:
Prevalence 27 (100%) 28 (100%) 25 (100%) 24 (92%)
Median score 3 3 3 2 =0.001‡
For abbreviations see table 2.
Post hoc Mann-Whitney U test showed significant diVerences between:
*Con and VaD (p<0.05) and between Con and AD (p<0.01)
†Con and AD (p=0.001) and between Con and VaD, Con and DLB (p<0.001)
‡Con and DLB (p<0.05) and between Con and AD, Con and VaD (p=0.001)
Table 4 White matter and basal ganglia hyperintensities
DLB
(n=27)
AD
(n=28)
VaD
(n=25) Con (n=26) p Value
Frontal:
Prevalence 22 (81%) 25 (89%) 24 (96%) 19 (73%)
Median score 2 2 3 1 <0.05*
Temporal:
Prevalence 3 (11%) 4 (14%) 3 (12%) 1 (4%)
Median score 0 0 0 0 NS
Parietal:
Prevalence 15 (56%) 13 (46%) 19 (76%) 8 (31%)
Median score 1 0 3 0 <0.01†
Occipital:
Prevalence 2 (7%) 3 (11%) 6 (24%) 3 (12%)
Median score 0 0 0 0 NS
Basal ganglia
prevalence 7 (26%) 6 (21%) 17 (68%) 3 (12%)
median score 0 0 2 0 <0.001‡
Total
prevalence 23 (85%) 25 (89%) 24 (96%) 19 (73%)
median score 3 4 8 1 <0.001§
For abbreviations see table 2.
Post hoc Mann-Whitney U test showed significant diVerences between:
*Con and AD (p<0.05) and between Con and VaD (p<0.01)
†Con and DLB, Con and AD (p<0.05), and between Con and VaD (p<0.001)
‡VaD and all other groups (p<0.001)
§Con and DLB, Con and AD, VaD and DLB (p<0.05), between VaD and AD (p<0.01), and
between VaD and Con (p<0.001)
68 Barber, Scheltens, Gholkar, et al
Total deep hyperintensity scores (sum of the
frontal, temporal, parietal, occipital, and basal
ganglia scores) were significantly higher in all
dementia groups compared with controls (vas-
cuylar dementia median score=8 v control
median score=1, p<0.001; dementia with
Lewy bodies median score=3, and Alzheimer’s
disease median score=4 v control median
score, p<0.05). Comparing the dementia
groups, patients with vascular dementia had
higher total lesion scores than those with
Alzheimer’s disease (p<0.01) and dementia
with Lewy bodies (p<0.05). Overall, basal gan-
glia lesions were specifically associated with
vascular dementia compared with all other
groups (vascular dementia 68%, dementia with
Lewy bodies 26%, Alzheimer’s disease 21%,
controls 12%; p<0.001).
A link between regional changes in white
matter and specific non-cognitive symptoms in
dementia patients was seen. The presence of
frontal WMHs was associated with higher
depression scores (mean MADRS score for
patients with frontal WMHs =8.3 v without
=3.4; p<0.05). The presence of delusions
(p<0.01) and visual hallucinations (p<0.05)
was associated with the absence of occipital
WMHs. No patient with delusions (n=34) had
WMHs, and only one patient with visual
hallucinations (n=29) had occipital WMHs.
Auditory hallucinations showed a similar trend
(p=0.06). White matter hyperintensity scores
Axial proton density MRI showing white matter lesions and ratings: (A) normal control (PVH score=0; WMH score=0);
(B) patient with vascular dementia (PVH: frontal caps=2, occipital caps=2; WMH frontal=5, parietal=6); (C) patient
with pathologically confirmed dementia with Lewy bodies (PVH: frontal caps=2, occipital caps=1; WMH frontal=2,
parietal=3); (D) patient with pathologically confirmed Alzheimer’s disease bodies (PVH: frontal caps=2, occipital caps=2;
WMH frontal=6, parietal=6).
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did not correlate with age or cognitive
impairment.
Discussion
This is the first study to examine the presence
of changes in white matter on MRI in demen-
tia with Lewy bodies. The inclusion of patients
with Alzheimer’s disease and patients with vas-
cular dementia allowed comparison of changes
in white matter between the three major types
of late life dementia. Periventricular hyperin-
tensities and WMHs were found to occur often
in patients with dementia with Lewy bodies,
Alzheimer’s disease, vascular dementia, and
aged matched normal controls. These changes
were, however, significantly more extensive in
the dementia groups compared with controls.
The major strengths of this study include the
recruitment of a representative community
sample of elderly patients with late life demen-
tia, well matched for age, sex, education, and
duration of illness. Brain MRI was acquired
using a standardised protocol, and changes in
white matter were assessed blind by an experi-
enced rater using a validated scale which
provided detailed information on the fre-
quency, size, and location of lesions. A
potential criticism of this study is the reliance
on clinical, rather than pathological, diagnoses.
However, clinical diagnosis were made after
detailed assessments and in accordance with
standardised criteria. In the case of dementia
with Lewy bodies, we have shown that the
clinical criteria have a high specificity (0.95)
indicating few false positive clinical
diagnoses.31 A recent clinicopathological vali-
dation of current clinical criteria for dementias
found a similar level of specificity (1.00), but
low sensitivity (0.22), for the consensus
diagnosis of probable dementia with Lewy
bodies.32 Overall the clinical criteria seem to
have a high positive predictive value for pathol-
ogy of dementia with Lewy bodies itself,
although the diagnosis does not exclude the
possibility of mixed disease.32 The profile of
patients with dementia with Lewy bodies stud-
ied conformed well with other published
cohorts.33 Pathological confirmation of diagno-
sis has since been acquired in four patients
(dementia with Lewy bodies n=2; Alzheimer’s
disease n=2).
PERIVENTRICULAR HYPERINTENSITIES
Periventricular hyperintensities were found in
all patients with dementia and 92% of controls.
Previous reports have found PVHs to occur in
44% to 100% of patients with Alzheimer’s dis-
ease, 70% to 100% with vascular dementia,
and 8% to 92% of elderly controls.1–3 In
common with other studies,9 11 34–36 a positive
correlation between the PVHs and age was also
found. The high prevalence of PVHs in this
study may therefore reflect, in part, the age of
patients.
As found previously, PVHs were more severe
in dementia patients than in controls.6 9 11 37
However, not all PVHs were equal in this
regard. Bands and occipital caps, by contrast
with frontal caps, were more severe and
common in dementia groups than in controls.
The near ubiquitous presence of frontal caps
lends further support to the notion that they
occur as a normal, age related change.38 39 His-
tologically, frontal PVHs probably result from
areas of demyelination and astrocytic gliosis.40
Divergence in the severity of periventricular
bands and occipital caps between demented
and non-demented patients suggests that
pathological processes contribute to their
development. The convergence of results
within the dementia groups would argue in
favour of a common pathogenesis. Interest-
ingly, Fazekas et al10 found that patients with
Alzheimer’s disease had significantly more
PVHs than controls but that this association
was not independently linked to the disease;
rather it seemed to be related to atrophy as
measured by ventricular enlargement. Other
studies have also found an association of PVHs
and atrophy,41 and in vitro pathological studies
indicate that PVHs are associated with loss of
the ependymal lining, demyelination, and
gliosis.42–44 Damage to the integrity of the
ependymal lining may in turn result in
abnormal dynamics of CSF and increased
water content.34 42 43 Histological studies of
PVHs in dementia with Lewy bodies are
necessary to establish whether similar changes
occur.
The absence of a link between PVHs and the
clinical features of dementia with Lewy bodies
was consistent with negative reports involving
non-demented elderly patients, patients with
Alzheimer’s disease, and patients with vascular
dementia.2 The relation between PVHs seen on
MRI and clinical features remains unclear.
Perhaps, as some authors have suggested, MRI
is more sensitive at detecting PVHs, but CT is
more specific and detects lesions which are
more tightly coupled with pathological change
and outcome.45
WHITE MATTER AND BASAL GANGLIA
HYPERINTENSITIES
White matter hyperintensities also occurred
often in all groups and diVerences between
demented and non-demented patients largely
resulted from variations in the severity and dis-
tribution of lesions. The pattern of WMHs in
dementia with Lewy bodies was broadly similar
to Alzheimer’s disease, but less extensive than
vascular dementia. The prevalence of WMHs
in vascular dementia and Alzheimer’s disease
conformed well with previous studies, which
have detected WMHs in up to 100% of
patients with vascular dementia7 12 and be-
tween 60%-100% of patients with Alzheimer’s
disease.2
The pathological correlates of WMHs in
dementia with Lewy bodies have not yet been
determined. The similar pattern of hyperinten-
sities in dementia with Lewy bodies and
Alzheimer’s disease suggests that they may
share a convergence in white matter pathology.
White matter lesions in Alzheimer’s disease
have been linked to ischaemic changes46 but
histological findings from other studies have
identified various abnormalities, including di-
lated perivascular spaces, arteriosclerosis, par-
tial loss of myelin and axons, gliosis, lacunar
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infarcts, and congenital diverticula.3 Clearly
not all WMHs result from ischaemic damage
and postmortem examination, ideally preceded
by postmortem brain MRI, is necessary to
determine the nature of white matter pathology
in dementia with Lewy bodies. In vivo charac-
terisation of WMHs using proton magnetic
resonance spectroscopy may also provide
useful pathological and diagnostic
information.47
The pronounced increase of basal ganglia
lesions in vascular dementia is consistent with
previous reports5 7 12 48 49 and suggests that
these changes may be useful as a diagnostic aid
in the diVerential diagnosis of vascular demen-
tia from dementia with Lewy bodies as well as
Alzheimer’s disease.12 Interestingly, the lack of
an association between dementia with Lewy
bodies and basal ganglia hyperintensities indi-
cates that these lesions are unlikely to contrib-
ute to the development of parkinsonism in
dementia with Lewy bodies.
There are contrasting reports on the associ-
ation between changes in white matter and
cognitive function.3 4 Discrepancies may be
explained by methodological diVerences. In
common with many other studies, the rating of
white matter lesions in this study was not volu-
metric. Semiquantitative rating scales may not
be suYciently sensitive to detect correlations
with cognition unless sample size is large.50 By
contrast, positive correlations have been re-
ported with moderate sample sizes using volu-
metric measures.51 52 In addition, in healthy
patients a “threshold” eVect has been reported
such that cognitive deficits only become
evident beyond a certain severity of changes in
white matter.51 Longitudinal studies might
provide further insights in to the nature of any
interaction between WMHs, cognitive func-
tion, and disease progression.
Non-cognitive features of dementias occur
commonly and are clinically important. There
is growing evidence that frontal and subcortical
WMHs are implicated in late life depression
and influence outcome, possibly by disruption
of frontal-subcortical circuits.9 53–56 The find-
ings of this study suggest that frontal WMHs
may also be relevant in understanding depres-
sion in dementia, and imply a common patho-
physiology of depression irrespective of
diagnosis.52
The association of psychotic symptoms with
specific brain abnormalities in dementias
remains controversial. Howanitz et al57 studied
patients with Alzheimer’s disease and found
that hallucinations were associated with cer-
ebral atrophy and enlarged third ventricles but
not abnormalities in white matter, though they
did not examine regional changes in white
matter. In this study, there was a negative
association between occipital WMHs and psy-
chosis which was not explained by group
diVerences between dementia with Lewy bod-
ies (who hallucinate a lot) and other groups
(who hallucinate less). This findings could
imply that a “disease” free occipital lobe,
presumably with abnormalities located in other
brain regions, is necessary to develop psycho-
sis, and that disruption of neural circuits
involving visual association areas might prevent
hallucinations. Using functional MRI Howard
et al58 have suggested that visual hallucinations
are, at least in part, located in the primary
visual cortex, raising the possibility that strate-
gically located lesions in white matter may dis-
rupt this process. Whether occipital WMHs
might suppress visual hallucinations is clearly
an area which requires further investigation.
Conclusion
Periventricular hyperintensities were found to
be common in dementia with Lewy bodies as
well as Alzheimer’s disease, vascular dementia,
and aged matched controls, but were uniformly
more severe in all major types of dementia
compared with controls. This could indicate
that PVHs result from a common pathogen-
esis, possibly related to brain atrophy. The pat-
tern of deep hyperintensities in dementia with
Lewy bodies was broadly similar to Alzheimer’s
disease and both groups showed modest
increases in the severity of changes in white
matter compared with controls. Overall
WMHs and basal ganglia lesions were most
pronounced in patients with vascular demen-
tia. A link between the presence of frontal
WMHs and depression and the absence of
occipital WMHs and psychotic symptoms was
found. This has important implications for
understanding the neurobiological basis of
these symptoms.
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